June 2026 in Science at MED MUNI
Here is an overview of the most interesting achievements in science and research at our faculty leading up to the summer break.
Register for the new CREATIC LabtoP talks webinars!
Want to know how ATMPs make their way from the lab to patients? Register now for the CREATIC LabtoP talks webinar series!
LabtoP talk "From Hospital Bench to Market: IP, Ownership, and Access Dilemmas in Academic ATMPs"
Date: April 10, 2026 | 15:00–16:00 CET
Speakers: Ana Nordberg, Lund University a Gabriela Maria Lenarczyk and & Jakob Wested, z CeBIL, University of Copenhagen
The first webinar in the CREATIC LabtoP talk series will explore how multidisciplinary teams, collaboration between laboratories and hospitals, and intellectual property considerations influence innovation and patient access to advanced therapy medicinal products (ATMPs). The webinar will focus on authorship, ownership, and governance across laboratories and institutions, as well as the impact of these factors when therapies transition from non-commercial or pre-commercial pathways into market-oriented development.
LabtoP talk "Hospital Exemption in Policy and Practice: European Variation and the CREATIC Case in the Czech Republic"
Datum: May 21, 2026 | 14:00–15:00 CET
Speakers: Zainab Afshan Sheikh, CeBIL, University of Copenhagen, a Zora Čechová, CoE CREATIC, MU
European Hospital Exemption (HE) rules significantly influence patient access to advanced therapy medicinal products (ATMPs) as well as innovation. The webinar combines policy perspectives with practical experience, exploring differences in HE implementation across the EU, the impact of underlying ideas about care, risk, and innovation, and the practical pathways for bringing ATMPs to patients in the Czech Republic.
LabtoP talk "Patient and Relative Perspectives on Experimental ATMP Treatment"
Date: June 11, 2026 | 14:00–15:00 CET
Speaker: Zainab Afshan Sheikh, CeBIL, University of Copenhagen
The third webinar in the CREATIC LabtoP talk series presents the perspectives of patients and their families on treatment with advanced therapy medicinal products (ATMPs). Despite regulatory frameworks and clinical innovations, patients often navigate these treatments under conditions of uncertainty, hope, and ethically challenging decisions. The webinar highlights how real patient experiences influence access to innovative care.
